eXegenics: Dr.Frost Continues His Hot Hand
by H.S. Ayoub
BioHealth Investor.com
Back in February, I recommended investing in Continucare (CNU) after doctor Phillip Frost, founder of Ivax Corporation, purchased shares of the healthcare company.
I also explained how it seemed that anything Dr.Frost touches turns into gold. His large purchase of shares of Ladenburg Thalmann Financial Services Inc (LTS) catapaulted the stock to multiple returns, and I continue to hold shares in LTS.
Just last Thursday, March 22nd, Dr.Frost and his group purchased controlling shares of Getting Ready Corporation (GTRY.OB) at around $1.25 a share. The stock ended trading on Tuesday at $2.99 a share!
Today, eXegenics (EXEG.OB), which Dr.Frost and his investment group invested in recently, announced that the empty shell company has agreed to merge with two eye disease biotech firms, and form a new company called Opko Corporation.
Opko will be headquartered in Miami, Dr.Frost's business stronghold, and will utilize Acuity Pharmaceuticals and Froptix Corporation's novel eye disease drug programs.
Acuity holds the rights to a drug that successfully completed Phase II clinical trials for wet age-related macular degeneration and diabetic macular edema.
Froptix has a number of drug candidates in preclinical development to treat dry age- related macular degeneration and other ophthalmic diseases. The company also intends to develop complimentary diagnostic tools.
Both companies were privately held.
What really was interesting in Exegenics' press release today was this statement, "...intends to apply to have its shares listed on the American Stock Exchange"
Shares of Exegenics closed Tuesday's trading session at $3.28 a share, after closing at $2.52 the day before. I purchased shares at $1.95 shortly after the closing of Dr.Frost's purchase a couple of months ago.
Here are Dr.Frost stocks I hold:
LTS
bought= $1.09
high= $3.74
CNU
bought= $3.03
high= $3.69
EXEG.OB
bought= $1.95
high= $3.29
Here are some stocks that Dr.Frost has purchased shares of which I do not hold in my portfolio:
Non-Invasive Monitoring Systems Inc.
(NIMU.OB)
Castle Brands
(ROX)
Cellular Technical Services Co.
(CTSC.OB)
Getting Ready Corporation
(GTRY.OB)
Source: BioHealhInvestor.com
_____________________
BioHealth Investor.com
Back in February, I recommended investing in Continucare (CNU) after doctor Phillip Frost, founder of Ivax Corporation, purchased shares of the healthcare company.
I also explained how it seemed that anything Dr.Frost touches turns into gold. His large purchase of shares of Ladenburg Thalmann Financial Services Inc (LTS) catapaulted the stock to multiple returns, and I continue to hold shares in LTS.
Just last Thursday, March 22nd, Dr.Frost and his group purchased controlling shares of Getting Ready Corporation (GTRY.OB) at around $1.25 a share. The stock ended trading on Tuesday at $2.99 a share!
Today, eXegenics (EXEG.OB), which Dr.Frost and his investment group invested in recently, announced that the empty shell company has agreed to merge with two eye disease biotech firms, and form a new company called Opko Corporation.
Opko will be headquartered in Miami, Dr.Frost's business stronghold, and will utilize Acuity Pharmaceuticals and Froptix Corporation's novel eye disease drug programs.
Acuity holds the rights to a drug that successfully completed Phase II clinical trials for wet age-related macular degeneration and diabetic macular edema.
Froptix has a number of drug candidates in preclinical development to treat dry age- related macular degeneration and other ophthalmic diseases. The company also intends to develop complimentary diagnostic tools.
Both companies were privately held.
What really was interesting in Exegenics' press release today was this statement, "...intends to apply to have its shares listed on the American Stock Exchange"
Shares of Exegenics closed Tuesday's trading session at $3.28 a share, after closing at $2.52 the day before. I purchased shares at $1.95 shortly after the closing of Dr.Frost's purchase a couple of months ago.
Here are Dr.Frost stocks I hold:
LTS
bought= $1.09
high= $3.74
CNU
bought= $3.03
high= $3.69
EXEG.OB
bought= $1.95
high= $3.29
Here are some stocks that Dr.Frost has purchased shares of which I do not hold in my portfolio:
Non-Invasive Monitoring Systems Inc.
(NIMU.OB)
Castle Brands
(ROX)
Cellular Technical Services Co.
(CTSC.OB)
Getting Ready Corporation
(GTRY.OB)
Source: BioHealhInvestor.com
_____________________
posted by Nico at
10:02 PM
3 Comments:
Why did Exeg.ob go to the pink sheets with the press that it is the intention on mgt to list on the AMEX?
companies sometimes have to remove their listings from the OTC/BB exchange while filing for inclusion on the AMEX.
This is normal protocol.
It should not take long for the new company, Opko, to list on the AMEX, but to how long exactly, I am not sure.
Rest assured, Dr.Frost, who is now the CEO, has a lot at stake in this new venture.
Look for Opko to begin trading on the AMEX soon.
Are you aware of this good news?
Form SC 13G eXegenics Inc Filed by: JOHNSON & JOHNSON
04-06-2007 05:28:00 PM
More SEC Filings
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=4799870
I know it's considered a peeny stock, but with solid investors, and management seems like there is little downside risk.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home